|
Originally published In Press as doi:10.1074/jbc.M201344200 on July 9, 2002
J. Biol. Chem., Vol. 277, Issue 37, 34329-34335, September 13, 2002
Skin-stage Schistosomula of Schistosoma
mansoni Produce an Apoptosis-inducing Factor That Can Cause
Apoptosis of T Cells*
Lin
Chen ,
Kakuturu V. N.
Rao§,
Yi-Xun
He , and
Kalyanasundaram
Ramaswamy ¶
From the Department of Biomedical Sciences, College
of Medicine, University of Illinois, Rockford, Illinois 61107 and
the § Department of Biomedical Engineering, Northwestern
University, Evanston, Illinois 60208
Received for publication, February 8, 2002, and in revised form, July 3, 2002
 |
ABSTRACT |
Skin-stage schistosomula of Schistosoma
mansoni were found to secrete molecules that are pro-apoptotic
for skin T lymphocytes as measured by annexin V staining, caspase-3
activity, caspase-8 activities, and DNA fragmentation. Caspase-8
activities in lymphocytes peaked ~8 h and caspase-3 activity peaked
~16 h after exposure to the parasite secretions. Subset analysis
showed that mainly CD4+ and CD8+ cells (but not
B cells) were susceptible to the parasite-induced pro-apoptotic
effect. In situ staining confirmed the presence of
apoptotic T cells around challenge parasites in the skin of naive or
immunized animals. Analysis of T cells to identify the potential
molecular pathway of the parasite-induced apoptosis showed increases in
the expression of Fas, FasL, and the Fas-associated death domain.
Blocking of FasL with a fusion protein reversed the parasite-induced
apoptosis, suggesting a role for the Fas/FasL-mediated pathway in the
parasite-induced T cell apoptosis. Subsequent analyses of the
secretions of skin-stage schistosomula identified the pro-apoptotic activity as being associated with a protein of ~23 kDa. This protein was termed S. mansoni-derived apoptosis-inducing factor.
 |
INTRODUCTION |
Schistosomiasis is a chronic debilitating disease that currently
affects >200 million people worldwide. Despite enormous effort to
control the disease, schistosomiasis continues to be one of the major
health hazards in parts of Africa, the Middle East, and Southeast Asia
(1). Development of an effective vaccine against this infection remains
elusive. Part of the problem may be due to the ability of the parasite
to evade host immune mechanisms (2-4). Compelling evidences from
recent studies suggest that schistosomes may actually exploit the host
immune responses for their own replication and transmission by
suppressing host immune responses (5). It is well established that
cells obtained from patients with chronic infection fail to respond to
antigens derived from Schistosoma mansoni (6-11). Similar
to these findings, one of our recent studies showed that lymphocytes
isolated from the skin or skin-draining lymph nodes of naive mice or
mice immunized previously with radiation-attenuated cercariae of
S. mansoni fail to respond to antigens in the excretory
secretory (ES)1 products of
skin-stage schistosomula (12). Morphologically, these cells appear
smaller and show nuclear and cytoplasmic condensation, suggestive of
cell death by apoptosis (13). Several lines of evidence suggest that
antigens of S. mansoni can induce apoptosis of host T
cells (7, 10, 11, 14, 15). In fact, the spontaneous immunoregulation
associated with egg-induced granulomatous inflammation (16-20) and the
global switch from a Th1-type to a Th2-type cytokine response in
schistosomiasis are believed to be due to apoptosis of T cells (10, 11,
18, 20, 21). Lundy et al. (22) recently reported that
when spleen cells or lymphocytes isolated from egg granulomas of
S. mansoni-infected animals were cultured in the presence of
soluble egg antigens (SEAs), a significant proportion of
CD4+ T cells in this preparation underwent apoptosis. This
pro-apoptotic effect appears to be mediated by B cells that express
functional FasL on their surface upon exposure to SEAs (22, 23). In
this study, we show that skin-stage schistosomula also similarly
secrete antigens that can up-regulate FasL expression on lymphocytes, thus promoting apoptosis of skin T cells. In addition, we have also
attempted to analyze the antigens secreted by skin-stage schistosomula
to identify the pro-apoptotic molecule.
 |
EXPERIMENTAL PROCEDURES |
Animals--
Male C57BL/6 mice (6-10 weeks old; Charles River
Laboratories, Wilmington, MA) were used in these experiments.
S. mansoni Infection and Immunization--
Biomphalaria
glabrata snails infected with S. mansoni were obtained
from Dr. Fred Lewis (Biomedical Research Institute, Rockville, MD). Cercariae were collected from infected snails as described previously (24), and mice were infected via the abdominal skin with 250 cercariae. For immunization, mice were immunized with 250 -radiation-attenuated (20,000 roentgen) live cercariae via the abdominal skin. 2 weeks after immunization, some of the mice were
subjected to challenge infection with 250 normal cercariae. For
in vitro studies, cercariae were transformed into
schistosomula, and ES products were collected as described previously
(25).
Cell Preparation and Culture--
A single cell suspension of
skin-draining (inguinal) lymph nodes was made, and cell viability was
determined by trypan blue exclusion. Cell viability was always >99%
in all our preparations. In some experiments, cells isolated from
skin-draining lymph nodes were separated into different subsets
(Thy1.2+, CD4+, CD8+, and B cells)
using magnetic beads (Miltenyi Biotech Inc., Auburn, CA, or
Dynal, Oslo, Norway) coated with monoclonal antibodies specific for the
respective cell subsets. Skin T cells (Thy1.2+) were
isolated as described previously (12). The purity of these cells was
>95% as confirmed by flow cytometry.
Detection of Annexin V-Binding--
1 × 106
cells isolated from the inguinal lymph nodes of infected mice,
naive mice or immunized mice were suspended in 200 µl of medium and
incubated with 60 µg/ml ES products for 24 h at 37 °C and 5%
CO2 in air. Following incubation, cells were washed and
stained with fluorescein isothiocyanate-labeled annexin V or propidium
iodide (BioSource International, Camarillo, CA). About 500-1000
cells were counted from each sample under a fluorescent microscope, and
the percentage of positive cells were calculated. In some experiments,
the percentage of annexin V-positive cells was determined by flow cytometry.
Detection and Time Kinetics of Caspase-3 and Caspase-8
Activities--
Approximately 1 × 106 lymphocytes
(CD4, CD8, or B cells) isolated from the skin or skin-draining lymph
nodes of naive or immunized/challenged mice were suspended in 200 µl
of medium and incubated with 100-150 schistosomula or 60 µg/ml ES products of schistosomula for 24 h at 37 °C and 5%
CO2 in air. Following incubation, cells were harvested and
stained with 50 µl of 10 µM PhiPhiLux substrate solution (Alexis Corp., San Diego, CA) for 45 min at 37 °C according to the manufacturer's instructions. About 500-1000 cells were counted
from each sample, and the percentage of caspase-positive cells was calculated.
Because there was an increase in both caspase-3 and caspase-8
activities after exposure to 60 µg/ml ES products, we performed a
time kinetics study (at 0, 8, 16, and 32 h after exposure) to measure differences in caspase-3 and caspase-8 activities in the skin-draining lymph node cells (5 × 106) collected
from naive C57BL/6 mice. Specific activities of caspase-3 and caspase-8
were determined by a colorimetric assay using kits purchased from MBL
(Nagoya, Japan).
Analysis of DNA Fragmentation--
DNA fragmentation was
evaluated as described by Kroemer et al. (26). Briefly, a
subset of lymphocytes were incubated with ES products (60 µg/ml) or
schistosomula (100-150/1 × 106 cells). 24 h
later, the cells were treated with digestion buffer (SDS/EDTA/proteinase K) and subjected to DNA electrophoresis on a 1%
agarose gel.
TUNEL Staining for Apoptotic Cells in the Skin--
Apoptotic
cells around the parasites in the skin of mice were evaluated by TUNEL
staining using an in situ apoptosis detection kit (R&D
Systems, Minneapolis, MN) following the instructions of the
manufacturer. Skin samples collected 24 h after challenge were
embedded in optimal cutting temperature compound (Sakura Finetek, Torrance, CA) and snap-frozen in liquid nitrogen. 8-µm-thick sections were cut using a cryostat and treated with proteinase K. Endogenous peroxidase activity was quenched using 1% hydrogen peroxide
in methanol. Sections were then incubated with biotinylated dUTP in the
presence of terminal deoxynucleotidyltransferase, which incorporates
the biotinylated nucleotides into the 3'-OH ends of fragmented DNA.
Finally, the biotinylated nucleotides were detected using
streptavidin-conjugated horseradish peroxidase, and color was developed
using diaminobenzidine substrate. Methyl green was used as a
counterstain. Adjacent sections were stained with a PE-labeled mouse
anti-CD3 monoclonal antibody (BD Pharmingen, San Diego, CA), and
isotype-matched nonspecific rat monoclonal antibody was used as a
control. Some sections were also stained with hematoxylin and eosin.
RNA Isolation and RT-PCR Analysis--
Total RNA was extracted
from Thy1.2+ cells, skin-draining lymph nodes, or the skin
of mice using Trizol (Invitrogen) according to the manufacturer's
recommendations and reverse-transcribed using RETROscript (Ambion Inc.,
Austin, TX). The cDNA of -actin in each sample was first
PCR-amplified (PerkinElmer Life Sciences) using -actin-specific
primers (27). Band densities of -actin in different samples were
adjusted to approximately the same level. Individual samples were then
PCR-amplified for Fas, FasL, and the Fas-associated death domain (FADD)
using specific primers. Primer sequences for Fas and FasL were as
published previously (28). Primers for FADD were
5'-ATGGAGCTCAAGTTCTTGTGC-3' and 5'-TCACTCTTGCTCACAGATTCC-3'
(GenBankTM accession number U50406). Primers for -actin,
Fas, FasL, and FADD amplified 550-, 281-, 590-, and 503-bp target
fragments, respectively. PCRs were performed as follows: for -actin,
3 min at 94 °C, 30 s at 57 °C, and 30 s at 72 °C for
30 cycles; for Fas, 3 min at 94 °C, 30 s at 62 °C, and
30 s at 72 °C for 32 cycles; for FasL, 3 min at 94 °C,
30 s at 60 °C, and 30 s at 72 °C for 30 cycles; and for
FADD, 3 min at 94 °C, 30 s at 49 °C, and 30 s at
72 °C for 35 cycles. The final elongation was followed by 5 min at
72 °C. The products were resolved on a 1.5% agarose gel and stained
with ethidium bromide.
Fas and FasL Detection by Flow Cytometry--
1 × 106 skin-draining lymph node cells from naive or immunized
mice were incubated with ES products (20, 60, or 80 µg/ml) for 24-48
h. Following incubation, cells were washed and incubated with rat
anti-mouse CD16/CD32 antibody (BD Pharmingen) to block non-antigen-specific binding of immunoglobulins to the Fc type III/II receptors. Following this, cells were incubated with fluorescein isothiocyanate-labeled rat anti-mouse CD3 antibody and PE-labeled anti-mouse Fas or anti-mouse FasL monoclonal antibody (BD Pharmingen) for 30 min at 4 °C and analyzed in a flow cytometer (Cytron,
Orthodiagnostic Inc., Raritan, NJ). Isotype-matched nonspecific
antibodies were used as negative controls.
Effect of FasL Blocking on ES Product-induced T Cell
Apoptosis--
1 × 106 Thy1.2+ cells
isolated from skin-draining lymph nodes of naive mice were cultured
with 60 µg/ml ES products or ES products plus 5 µg/ml recombinant
Fas-Fc fusion protein (Alexis Corp.) for 24 h and then
tested for annexin V binding. Recombinant S. mansoni
G-binding factor was used as a control recombinant protein.
Fractionation of ES Products to Identify Pro-apoptotic
Activity--
Proteins in the ES products of normal schistosomula were
size-separated initially into three different fractions by
ultrafiltration using Centricon concentrators (Amicon, Inc., Beverly,
MA). Fraction 1 contained molecules <3000 Da; fraction 2 contained
molecules between 3 and 30 kDa; and fraction 3 contained molecules >30
kDa. Each fraction (60 µg/ml) was then tested for the presence of
pro-apoptotic activity. These studies narrowed the pro-apoptotic
activity to molecules between 3 and 30 kDa. Subsequently, Sephacryl
S-100 high-resolution gel filtration medium (Amersham Biosciences) was used to separate the protein bands in fraction 2. The protein band that
showed pro-apoptotic activity was then resolved on a 12%
SDS-polyacrylamide gel, transferred onto a polyvinylidene difluoride
membrane (Bio-Rad), and sent to the Protein Structure Facility at the
University of Michigan for N-terminal amino acid sequencing.
Statistical Analysis--
Statistical analysis was performed
using a Mann-Whitney U rank sum test using Sigmastat Version
2.0 (Jandel Scientific, San Rafael, CA).
 |
RESULTS |
Effect of ES Products on Cell Viability--
Addition of ES
products of normal schistosomula to lymphocytes collected from
skin-draining (inguinal) lymph nodes of naive mice resulted in a
significant decrease in cell viability as measured by propidium iodide
staining. At 24 h after exposure to 60 µg/ml ES products,
34.3 ± 7.5% of cells were positive for propidium iodide.
However, when cells were incubated with medium alone, only 13.2 ± 1.3% of cells were positive (p < 0.05) (Fig.
1A). A similar decrease in
cell viability was obtained when cells from naive animals were cultured
with 100-150 schistosomula of S. mansoni (data not shown).
Under light microscopy, a substantial proportion of cells exposed to
the parasites or their ES products appeared smaller with condensed
cytoplasm and nuclei (data not shown). Subsequent staining of the cells
with annexin V and propidium iodide showed that 62.4 ± 8.9% of
cells incubated with ES products (60 µg/ml) were positive for annexin
V, whereas only 12.8 ± 2.4% of cells incubated with medium alone
were positive for annexin V (p < 0.01) (Fig.
1A). A similar decrease in cell viability was observed when
Thy1.2+ cells isolated from the skin of immunized mice were
incubated with 100-150 schistosomula or their ES products (data not
shown). These observations suggest that the lymphocytes might undergo apoptosis upon exposure to the parasites or their secretions.

View larger version (60K):
[in this window]
[in a new window]
|
Fig. 1.
1 × 106 cells isolated from
the skin or skin-draining lymph nodes of naive or immunized animals
were cultured in medium alone (M) or with ES products (60 µg/ml) or 100-150 schistosomula (SM) for 24 h.
Following incubation, apoptosis was measured by annexin V and
propidium iodide staining and counting 500-1000 cells under a
fluorescence microscope (A), by measuring caspase-3 activity
in various subset of lymphocytes using PhiPhiLux substrate and
counting 500-1000 cells under a fluorescence microscope
(B), and by evaluating DNA fragmentation in different
subsets after treatment with DNA digestion buffer and separation on a
1% agarose gel (C). Data presented are representative of
one of three to five similar experiments using five to seven mice per
group in each experiment. A and B show means ± S.D. of the percentage of positive cells. * and **,
p < 0.05 and p < 0.01 compared with
the medium control, respectively.
|
|
Subset of Lymphocytes That Undergo Apoptosis in Response to the
Parasites or Their Secretions--
In these studies, we monitored
caspase-3 activity as a marker of apoptosis in various subsets of
lymphocytes (CD4, CD8, and B cells) after incubation with 100-150
schistosomula or their ES products. Significant increases in caspase-3
activity were observed in both CD4+ and CD8+
subsets of lymphocytes from either naive or immunized mice after exposure to the parasites or their secretions, whereas in B cells, the
caspase-3 staining was not significantly different from medium controls
(Fig. 1B). Similar results were obtained when
Thy1.2+ cells isolated from the skin of immunized and
challenged mice were exposed to the parasites or their secretions
in vitro (Fig. 1B).
Effect of ES Products on DNA Fragmentation in T Cells--
The
pro-apoptotic effect of schistosomula or their ES products on CD4 and
CD8 subsets of T cells was then further confirmed by analyzing their
DNA for fragmentation. These studies showed typical fragmentation of
DNA as evidenced by the characteristic ladder formation in both CD4 and
CD8 subsets of lymphocytes from both naive and immunized mice that were
exposed to schistosomula or their ES products (Fig. 1C). No
DNA fragmentation was evident in cells incubated with medium alone
(Fig. 1C) or in B cells that were incubated with the
parasites or their secretions (data not shown). DNA fragmentation was
also evident in Thy1.2+ cells isolated from the skin of
immunized and challenged mice following exposure to the parasites or
their secretions (Fig. 1C).
Time Kinetics of Caspase-3 and Caspase-8 Activities in
Skin-draining Lymph Node Cells--
Preliminary studies also showed an
increase in caspase-8 activities in T cells exposed to ES products
(data not shown). Therefore, we wanted to evaluate the time kinetics of
the appearance of caspase-3 and caspase-8 activities in T cells exposed
to the ES products. These studies showed that caspase-8 activities
appeared first and peaked in the cells ~8 h after incubation (Fig.
2). Thereafter, there was a sharp
decline; and by 16 h, caspase-8 activities in the cells were near
base-line levels. On the other hand, caspase-3 activity showed a steady
increase from 8 h after exposure to ES products and peaked at
~16 h (Fig. 2).

View larger version (9K):
[in this window]
[in a new window]
|
Fig. 2.
Time courses of caspase-8 and caspase-3
protease activities. 5 × 106 skin-draining lymph
node cells from naive C57BL/6 mice were cultured with 60 µg/ml ES
products for 0, 8, 16, and 32 h. Cells were harvested at different
time points, and caspase-8 or caspase-3 protease activity was examined
by a colorimetric protease assay. Data presented are from one of two
similar experiments.
|
|
In Situ Analysis of Apoptotic Cells around the Parasites in the
Skin--
Previous studies showed that mononuclear cells accumulate
around challenge parasites in the skin of immunized animals (24). Despite this marked cellular reaction around the parasite, very few
normal parasites appear to die in the skin (24). However, if the
parasites are attenuated by -rays, several of them are retained in
the skin; and among these, a few die due to the severe cellular
reaction. Because our above results showed that secretions from normal
schistosomula can cause apoptosis of T cells, we wanted to evaluate
whether T cells that accumulate around normal parasites in the skin
undergo apoptosis, thereby helping the parasite to escape. We used
TUNEL staining to demonstrate apoptotic cells in the skin. These
studies showed the presence of many apoptotic cells around migrating
challenge parasites in the skin of immunized and challenged animals
(Fig. 3E). Apoptotic cells
were also seen around schistosomula in the skin of infected naive mice
(Fig. 3C). No apoptotic cells were present in normal skin
(Fig. 3A) or in the skin of immunized mice (Fig.
3B). Simultaneous immunohistochemical analyses of adjacent
sections with anti-CD3 antibodies showed that the majority of the cells
around normal schistosomula (Fig. 3D) in the skin of
immunized and challenged animals are T cells (Fig. 3F).
There was no PE reactivity in sections incubated with isotype-matched
antibody controls (data not shown).

View larger version (68K):
[in this window]
[in a new window]
|
Fig. 3.
TUNEL staining for apoptotic cells in
the skin. Skin biopsy samples collected from naive
(A), immunized (B), infected naive
(C), and immunized and challenged (D-F) mice
were processed for cryostat sectioning and stained with biotinylated
dUTP (A-C and E), hematoxylin and eosin
(D), or PE- labeled anti-CD3 antibody (F).
Arrows indicate cut sections of the parasites. The
brown-staining cells in C and E are
apoptotic cells. Original magnification was ×400. Data presented
are from one of three similar experiments using five mice per
group.
|
|
Fas and FasL Expression in Skin-draining Lymph Node T Cells after
Exposure to ES Products--
To determine the potential molecular
pathway of the parasite-induced apoptosis in T cells, we analyzed the
expression of Fas and FasL in skin-draining lymph node T cells from
both naive and immunized mice after exposure to ES products. These
studies showed a dose- and time-dependent increase in
Fas+ CD3+ cells following exposure to ES
products (Fig. 4A). Maximum
expression was seen when cells were incubated with 60 µg/ml ES
products for 48 h. Compared with medium controls, a higher
proportion of cells from naive mice expressed Fas on their surface in
response to ES products than cells from immunized animals (Fig.
4A). Exposure to ES products also resulted in a significant
increase in the number of FasL+ CD3+ cells
isolated from both naive and immunized animals (Fig. 4B). However, the levels of FasL detection were low and were significant only at higher concentrations of ES products.

View larger version (35K):
[in this window]
[in a new window]
|
Fig. 4.
Fas (A) and FasL
(B) expression in CD3+ cells.
Skin-draining lymph node cells isolated from naive or immunized mice
were incubated with different concentrations of ES products (20, 60, or
80 µg/ml) for 24 or 48 h. Following incubation, cells were
stained with a fluorescein isothiocyanate-labeled anti-CD3+
antibody and a PE- labeled anti-Fas or anti-FasL antibody. The
percentage of double-positive cells was evaluated by flow cytometry.
Data presented are from one of five similar experiments. * and **,
p < 0.05 and p < 0.01 compared with
the medium control, respectively.
|
|
Expression of Molecules Associated with Apoptosis in T Cells,
Skin-draining Lymph Node Cells, and the Skin--
RT-PCR analysis
showed a relative increase in the message levels for Fas, FasL, and
FADD in T cells isolated from the skin-draining lymph nodes of naive
mice following incubation with ES products (Fig.
5). Similar semiquantitative increases in
the transcript levels of Fas, FasL, and FADD were observed in the skin
tissue at the site of infection and in the skin-draining lymph nodes of
naive animals or immunized mice following a challenge infection with
normal cercariae (Fig. 5). These transcripts were low or absent in the
skin and draining lymph nodes of uninfected naive mice (Fig. 5).

View larger version (57K):
[in this window]
[in a new window]
|
Fig. 5.
Expression of Fas, FasL, and FADD mRNAs
in T cells, skin-draining lymph nodes, and skin. 1 × 106 Thy1.2+ cells isolated from skin-draining
lymph nodes of naive mice were exposed to 60 µg/ml ES products for
24 h. Tissues (skin-draining lymph nodes and skin) for RT-PCR were
collected 24 h after infection with S. mansoni
(Inf) or 24 h after challenge infection of mice
immunized 2 weeks previously with attenuated parasites
(Im&ch). Lymph nodes and skin collected from naive animals
served as controls. Gene-specific primers were used in RT-PCR to
determine the transcript levels of Fas, FasL, FADD, and -actin. PCR
products were then separated on a 1.5% agarose gel and stained with
ethidium bromide. Samples were pooled from three mice, and data
presented are representative of one of three similar experiments.
|
|
Effect of Blocking FasL on T Cell Apoptosis--
Addition of
recombinant Fas-Fc fusion protein to T cell cultures incubated with 60 µg/ml ES products resulted in 83.6% reduction in annexin V-positive
cells (Fig. 6) compared with control
wells that contained ES products, but no blocking recombinant proteins. The percentage of annexin V-positive T cells in Fas-Fc fusion protein-treated wells (27.4 ± 5.7%) was comparable to that in medium controls with no ES products (20.9 ± 3.5%). Addition of a
control recombinant protein (S. mansoni G-binding factor)
had no effect on the percentage of ES product-induced annexin
V-positive cells (data not shown).

View larger version (11K):
[in this window]
[in a new window]
|
Fig. 6.
Effect of blocking FasL on parasite-induced T
cell apoptosis. 1 × 106 Thy1.2+
cells isolated from skin-draining lymph nodes of naive mice were
cultured with 60 µg/ml ES products or ES products plus 5 µg/ml
recombinant Fas-Fc fusion protein for 24 h. Apoptosis was
evaluated by determining the percentage of annexin V-positive cells.
*, p < 0.01 compared with the medium control.
|
|
Characterization of the Apoptosis-inducing Activity in the ES
Products of Normal Schistosomula--
To identify the
pro-apoptotic molecule in the ES products of normal schistosomula,
we separated the ES products into three fractions and incubated them
with T cells isolated from the skin-draining lymph nodes of naive mice.
These studies showed that significant pro-apoptotic activity, as
measured by annexin V staining, was associated with fraction 2 (3-30
kDa) and fraction 3 (>30 kDa), although the majority of the activity
was present in fraction 2 (Fig. 7).
Fraction 1 (<3000 Da) did not contain any annexin Vbinding
activity. Subsequently, bands in fraction 2 were isolated by gel
filtration, and each was tested for its ability to induce apoptosis in
T cells. These experiments narrowed the pro-apoptotic activity in the
ES products of normal schistosomula to a protein of ~23 kDa (Fig.
7).

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 7.
Pro-apoptotic activity is associated with a
molecule between 3 and 30 kDa in the ES products of normal
schistosomula. ES products were divided into three fractions,
fraction 1 (Fr 1; <3 kDa), fraction 2 (Fr 2;
3-30 kDa), and fraction 3 (Fr 3; >30 kDa). Bands in
fraction 2 were again separated by gel filtration. Each peak (at 60 µg/ml) was then tested for its ability to induce apoptosis of T cells
(isolated from the skin-draining lymph nodes of naive mice) by staining
for annexin V. Only two peaks (23 and 28 kDa) are shown. About 500 cells were counted under a fluorescence microscope. Values are
representative of one of three similar experiments and are means ± S.D. of the percentage of positive cells. * and **,
p < 0.05 and p < 0.001 compared with
the medium control (M), respectively. ES products from
normal schistosomula were used as a positive control.
|
|
N-terminal Amino Acid Sequence of the 23-kDa
Pro-apoptotic Protein--
As a preliminary step to identify the
molecular structure of the pro-apoptotic molecule, we performed
N-terminal amino acid sequencing on the 23-kDa protein. This analysis
revealed the sequence as KDMITEDEMFTDSHCPRVVA. We believe that
these data will potentially help in cloning the pro-apoptotic gene and
may further allow extensive sequence analyses.
 |
DISCUSSION |
The results presented in this study show that
skin-stage schistosomula of S. mansoni can release molecules
in their secretions that can induce apoptosis of T cells in the skin.
Subsequent analysis suggested that this pro-apoptotic activity is
associated with a molecule of ~23 kDa. Preliminary studies to
identify the molecular pathway by which T cells undergo apoptosis in
response to the parasite or its secretion suggested a possible role for
Fas/FasL mechanisms. Based on this finding, it is suggested that the
parasite may use T cell apoptosis as a potential mechanism to subdue
initial cellular responses in the skin (24).
Following immunization with radiation-attenuated parasites, there is a
significant increase in the numbers of IFN- -secreting CD4+ cells in the skin (12) and skin-draining lymph nodes
(12, 29, 30). Functional analyses suggest that these IFN- -secreting T cells are potentially the effector cells that confer protection against challenge parasites in the lungs (30, 31). However, in one of
our earlier studies, when we isolated T cells from the skin or
skin-draining lymph nodes of immunized animals and incubated them
in vitro with ES antigens from skin-stage schistosomula, they failed to proliferate or secrete IFN- (12). Nevertheless, significant amounts of IFN- were produced when these cells were stimulated in vitro with mitogen, antigens from
radiation-attenuated parasites or with ES antigens from lung-stage
schistosomula. This suggests that the normal skin-stage schistosomula
might modulate the function of skin or skin-drain lymph node cells to
escape host detection in the skin (12). When observed under light
microscopy, cells stimulated with ES antigens collected from normal
skin-stage schistosomula appear smaller with condensation of cytoplasm
and nuclei (13), characteristics that are typical of cells undergoing apoptosis (32, 33).
The ability of schistosomes to induce apoptosis in host cells is well
documented in the literature (14). The most striking of the
documentation is the studies presented by Carneiro-Santos et
al. (7), who suggested an important role for T cell apoptosis in
immunoregulation during chronic S. mansoni infection in
humans. When peripheral blood CD3+ cells isolated from
chronically infected individuals with an asymptomatic intestinal form
of the disease were incubated with SEAs of S. mansoni,
nearly 30% of these cells became apoptotic (7). In the present study,
we have shown that similar to the egg stages, the skin-stage
schistosomula also may potentially contain antigens that can induce
apoptosis of T cells. However, the implication of this early T cell
apoptosis induced by skin-stage schistosomula may be potentially
significant and alarming in that the parasite may use apoptosis as a
mechanism to eliminate putative effector cells that accumulate around
them in the skin and thereby gain more time to adapt in the new host.
Previous histological and immunohistochemical analyses showed that
mononuclear cells accumulate around challenge parasites in the skin of
immunized animals (24). Despite the marked cellular reaction, very few parasites are retained in the skin (24, 31). The results from the
present study suggest that this might be because the parasites potentially force the cells that accumulate around them to undergo apoptosis.
Studies by Fallon et al. (11) suggest that the dramatic
switch in the cytokine response from the Th1 type to the Th2 type seen
in this infection following the onset of egg laying may be due to
significant apoptosis of T cells in the spleen. Especially Th1-type
cells seem to be more susceptible to the parasite-induced apoptosis
than Th2-type cells (20). Although we did not identify the cytokine
profile of T cells that undergo apoptosis in our studies, previously,
our group (12) and others (30, 31) have demonstrated that the cells
isolated from the skin-draining lymph nodes of immunized mice secrete
significant amounts of IFN- in response to mitogen or antigens from
irradiated parasite. However, these cells fail to respond to normal
parasites or their antigens. This selective parasite-induced
down-regulation of IFN- secretion by T cells isolated from the skin
and skin-draining lymph nodes of mice (12, 29) may be due to apoptosis
of Th1-type cells (21).
Interestingly, not only schistosomes, but other parasites such as
Necator americanus (34), Fasciola hepatica (35),
Paragonimus westermani (36), Taenia
crassiceps (37) Trypanosoma cruzi (38, 39),
Leishmania donovani (40), and Cryptosporidium parvum (41) are also known to induce apoptosis of host cells. It
has been suggested that the parasites may use host cell apoptosis as a
survival strategy to establish infection in their host by creating a
site of immune privilege around them (34). Although the mechanism of
this parasite-induced apoptosis is not fully understood, it appears
that the majority of these parasites induce an increase in caspase-3
activity within the host cell (14). In the present study, we have also
shown that caspase-3 activity is increased in T cells following
exposure of cells to the parasites or their secretions. Activation of
caspase-3 usually occurs when certain specific molecules, collectively
called death receptors, are triggered on the surface of lymphocytes
(32). Currently, five different death receptors have been described in
the literature. The best characterized death receptors are those
belonging to the tumor necrosis factor (TNF) receptor family of
proteins (42). These include TNF receptor-1, CD95 (Fas/APO-1), TNF
receptor-related apoptosis-mediated protein, and TRAIL
(TNF-related
apoptosis-inducing ligand)
receptors (DR-4 and DR-5). The respective ligands for these receptors
are TNF, FasL (CD95L), lymphotoxin- , and TRAIL. The general
signaling pathways of apoptosis induced by these receptors appear to be
similar (43). Initial attempts to identify the potential death
receptors triggered by skin-stage schistosomula showed a significant
increase in Fas and FasL on the surface of T cells
following exposure to the parasites or their secretions. Both flow
cytometry and RT-PCR results confirmed these findings. There was also
an increase in the expression of Fas and FasL in the skin and
skin-draining lymph nodes after infection, suggesting that the
pro-apoptotic effect induced by the skin-stage schistosomula may be
mediated via a Fas/FasL pathway. This contention was further validated
by in vitro blocking experiments. When Fas binding to FasL
was blocked using a Fas-Fc fusion protein, there was a significant reduction in ES product-induced T cell apoptosis, suggesting a central
role for Fas/FasL in skin-stage schistosomula-induced T cell apoptosis
in the skin. A similar FasL-mediated apoptosis of CD4+
cells may occur in egg-induced granulomatous inflammation in S. mansoni infection as well (18, 19, 22).
Binding of FasL to trimerized Fas on the surface of lymphocytes
recruits the intracellular adaptor molecule FADD, which in turn forms a
death-inducing signaling complex (42). This complex will activate
caspase-8, which is responsible for activating all of the downstream
cascade of caspases, including caspase-3 (44). Examination of the
different apoptotic signaling molecules within T lymphocytes after
activation with ES antigens of schistosomula showed increased
expression of FADD, caspase-8, and caspase-3, clearly suggesting the
sequence of apoptotic events happening within these cells. A time
course study showed that upon exposure to ES antigens from normal
skin-stage schistosomula, caspase-8 activity peaked first, followed by
caspase-3 activity. These changes started in the cells within hours
after exposure to the parasite antigens. Analysis of the skin tissue
collected from the site of infection confirmed that similar changes
occurred in vivo in the skin of naive or immunized mice
following infection.
Activated caspases will, in turn, induce proteolysis of many substrates
within the cells, including proteins involved in cell repair, cell
cycle control, signal transduction, and/or structural integrity (45).
Activation of caspases can also lead to proteolytic cleavage of DNA,
resulting in DNA fragmentation, which can be visualized on agar gel.
Exposure of lymph node cells to the parasites or their secretions
in vitro causes typical DNA fragmentation, further
confirming that parasite-induced pro-apoptotic changes occur in T lymphocytes.
Subset analysis of lymphocytes in the skin and skin-draining lymph
nodes showed that the skin-stage schistosomula induce apoptosis of
CD4+ and CD8+ T cells, but not B cells. Studies
by Lundy et al. (22) also showed that >30% of
CD4+ cells undergo apoptosis when they are exposed to SEAs
of S. mansoni. In these studies, B cells were found not to
undergo apoptosis; rather, a subset of B cells (B-1a cells) were shown
to impart the death signal to SEA-stimulated CD4+ cells by
expressing high levels of FasL (22, 23). Interestingly, in our studies,
removal of B cells did not affect ES antigen-induced T cells apoptosis.
Furthermore, because a fraction of CD3+ cells also express
FasL on their surface in response to ES products, it is possible that a
variety of cells are potentially induced by the parasite to express
FasL for mediating T cell apoptosis.
Migration of schistosomula through the skin induces a interleukin-10
response in the skin (12). Because interleukin-10 can potentially
induce apoptosis of T cells during S. mansoni infection (46), some of the pro-apoptotic activity observed in the skin may be
interleukin-10-mediated. Similarly, it is possible that other receptors
and adaptors in addition to Fas and FADD could be involved in this
parasite-induced pro-apoptotic mechanism. Further studies may help
identify whether any other redundant mechanisms are operative in the
parasite-induced apoptosis.
Initial attempts to identify the characteristics of the pro-apoptotic
molecule in the ES products of normal schistosomula narrowed the
activity to a fraction between 3 and 30 kDa. Subsequent fractionation
and analysis of the molecules within the 3-30-kDa fraction suggested
that the pro-apoptotic activity of skin-stage schistosomula is
associated with a protein band at ~23 kDa. Through amino acid
analysis, we have identified 20 sequences at the N terminus of the
23-kDa molecule. This will allow us to perform an extensive sequence
analysis of the protein and ultimately to clone the gene for the
pro-apoptotic molecule. Because this molecule induced significant
apoptosis of T cells, we coined the term S. mansoni-derived apoptosis-inducing factor (Smaf) for this
molecule(s). Exposure of the parasites to -irradiation eliminated
Smaf activity, and the pro-apoptotic effect of Smaf was evident only
when the cells were incubated with either live parasites or their ES
products. Similarly, when schistosomula were heat-inactivated (at
60 °C) and incubated with the skin-draining lymph node cells, there
was a significant reduction in the parasite-induced
apoptosis.2 This is the first
time that the presence of a pro-apoptotic molecule in the secretions of
human schistosomes has been demonstrated. We believe that the
skin-stage schistosomula release Smaf into their immediate surroundings
to potentially eliminate the effector cells that may accumulate around
them and thus escape the damaging assaults of the host. Neutralizing
the effects of Smaf may help increase development of early immune
responses against invading schistosomula in the skin.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grant AI 39066 (to K. R.). Life cycle stages of S. mansoni
were obtained from Dr. Fred Lewis through NIAID Contract N01-A1-55270
from the National Institutes of Health.The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence and reprint requests should be
addressed: Dept. of Biomedical Sciences, College of Medicine,
University of Illinois, 1601 Parkview Ave., Rockford, IL 61107. Tel.:
815-395-5696; Fax: 815-395-5666; E-mail: ramswamy@uic.edu.
Published, JBC Papers in Press, July 9, 2002, DOI 10.1074/jbc.M201344200
2
L. Chen and K. Ramaswamy, unpublished data.
 |
ABBREVIATIONS |
The abbreviations used are:
ES, excretory
secretory;
SEAs, soluble egg antigens;
TUNEL, terminal
deoxynucleotidyltransferase-mediated biotinylated UTP nick end
labeling;
PE, phycoerythrin;
RT, reverse transcription;
FADD, Fas-associated death domain;
IFN- , interferon- ;
TNF, tumor
necrosis factor;
Smaf, S. mansoni-derived
apoptosis-inducing factor.
 |
REFERENCES |
| 1.
|
World Health Organization Expert Committee on the Control of Schistosomiasis.
(1993)
Bull. WHO
71,
657-677[Medline]
[Order article via Infotrieve]
|
| 2.
| Terry, R. J., and Smithers, S. R. (1975) Symp. Soc.
Exp. Biol. 453-465
|
| 3.
|
Kolata, G.
(1985)
Science
227,
285-287[Free Full Text]
|
| 4.
|
Damian, R. T.
(1997)
Parasitology
115,
S169-S175
|
| 5.
|
McKerrow, J. H.
(1997)
Parasitology
115,
S107-S112
|
| 6.
|
Vieira, L. Q.,
Gazzinelli, G.,
Kusel, J. R., De,
Souza, C. P.,
and Colley, D. G.
(1986)
Parasite Immunol. (Oxf.)
8,
333-343
|
| 7.
|
Carneiro-Santos, P.,
Martins-Filho, O.,
Alves-Oliveira, L. F.,
Silveira, A. M.,
Coura-Filho, P.,
Viana, I. R.,
Wilson, R. A.,
and Correa-Oliveira, R.
(2000)
Parasite Immunol. (Oxf.)
22,
267-277
|
| 8.
|
Colley, D. G.,
Cook, J. A.,
Freeman, G. L., Jr.,
Bartholomew, R. K.,
and Jordan, P.
(1977)
Int. Arch. Allergy Appl. Immunol.
53,
420-433[Medline]
[Order article via Infotrieve]
|
| 9.
|
Colley, D. G.,
Todd, C. W.,
Lewis, F. A.,
and Goodgame, R. W.
(1979)
J. Immunol.
122,
1447-1453[Abstract/Free Full Text]
|
| 10.
|
Estaquier, J.,
Marguerite, M.,
Sahuc, F.,
Bessis, N.,
Auriault, C.,
and Ameisen, J. C.
(1997)
Eur. Cytokine Netw.
8,
153-160[Medline]
[Order article via Infotrieve]
|
| 11.
|
Fallon, P. G.,
Smith, P.,
and Dunne, D. W.
(1998)
Eur. J. Immunol.
28,
1408-1416[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Kumar, P.,
and Ramaswamy, K.
(1999)
Parasitol. Int.
48,
109-119[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Chen, L.,
and Ramaswamy, K.
(2001)
J. Vet. Parasitol.
15,
1-12
|
| 14.
|
DosReis, G. A.,
and Barcinski, M. A.
(2001)
Adv. Parasitol.
49,
133-161[Medline]
[Order article via Infotrieve]
|
| 15.
|
Remoue, F., To,
Van, D.,
Schacht, A. M.,
Picquet, M.,
Garraud, O.,
Vercruysse, J., Ly, A.,
Capron, A.,
and Riveau, G.
(2001)
Clin. Exp. Immunol.
124,
62-68[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Stadecker, M. J.,
Kamisato, J. K.,
and Chikunguwo, S. M.
(1990)
J. Immunol.
145,
2697-2700[Abstract]
|
| 17.
|
de Andres, B.,
Mueller, A. L.,
Blum, A.,
Weinstock, J.,
Verbeek, S.,
Sandor, M.,
and Lynch, R. G.
(1997)
Blood
90,
1267-1274[Abstract/Free Full Text]
|
| 18.
|
Rumbley, C. A.,
Zekavat, S. A.,
Sugaya, H.,
Perrin, P. J.,
Ramadan, M. A.,
and Phillips, S. M.
(1998)
J. Immunol.
161,
4129-4137[Abstract/Free Full Text]
|
| 19.
|
Rumbley, C. A.,
Sugaya, H.,
Zekavat, S. A.,
Perrin, P. J.,
and Phillips, S. M.
(2001)
Am. J. Trop. Med. Hyg.
65,
442-449[Abstract]
|
| 20.
|
Fallon, P. G.,
Richardson, E. J.,
Smith, P.,
and Dunne, D. W.
(2000)
Eur. J. Immunol.
30,
470-480[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Rumbley, C. A.,
and Phillips, S. M.
(1999)
Microbes Infect.
1,
499-504[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Lundy, S. K.,
Lerman, S. P.,
and Boros, D. L.
(2001)
Infect. Immun.
69,
271-280[Abstract/Free Full Text]
|
| 23.
|
Lundy, S. K.,
and Boros, D. L.
(2002)
Infect. Immun.
70,
812-819[Abstract/Free Full Text]
|
| 24.
|
Ramaswamy, K., He, Y.-X.,
and Salafsky, B.
(1997)
Exp. Parasitol.
86,
118-132[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Ramaswamy, K.,
Salafsky, B.,
Potluri, S., He, Y.-X., Li, J. W.,
and Shibuya, T.
(1995)
J. Inflamm.
46,
13-22[Medline]
[Order article via Infotrieve]
|
| 26.
|
Kroemer, G.,
Bosca, L.,
Zamzamin, N.,
Marchett, P.,
and Hortelano, S.
(1997)
in
Immunology Methods Manual
(Lefkovits, I., ed), Vol. 2
, pp. 1121-1122, Academic Press Ltd., London
|
| 27.
|
Benavides, G. R.,
Hubby, B.,
Grosse, W. M.,
McGraw, R. A.,
and Tarleton, R. L.
(1995)
J. Immunol. Methods
181,
145-156[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Chu, C. Y.,
and Tseng, J.
(2000)
J. Biomed. Sci.
7,
58-63[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Betts, C. J.,
and Wilson, R. A.
(1998)
Immunology
93,
49-54[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Mountford, A. P.,
Coulson, P. S.,
Pemberton, R. M.,
Smythies, L. E.,
and Wilson, R. A.
(1992)
Immunology
75,
250-256[Medline]
[Order article via Infotrieve]
|
| 31.
|
Pemberton, R. M.,
Smythies, L. E.,
Mountford, A. P.,
and Wilson, R. A.
(1991)
Immunology
73,
327-333[Medline]
[Order article via Infotrieve]
|
| 32.
|
Schneider, P.,
and Tschopp, J.
(2000)
Pharm. Acta Helv.
74,
281-286[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Hengartner, M. O.
(2000)
Nature
407,
770-776[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Chow, S. C.,
Brown, A.,
and Pritchard, D.
(2000)
Parasite Immunol. (Oxf.)
22,
21-29
|
| 35.
|
O'Neill, S. M.,
Brady, M. T.,
Callanan, J. J.,
Mulcahy, G.,
Joyce, P.,
Mills, K. H.,
and Dalton, J. P.
(2000)
Parasite Immunol. (Oxf.)
22,
147-155
|
| 36.
|
Shin, H. J.,
Cho, M. S.,
Kim, H. I.,
Lee, M.,
Park, S.,
Sohn, S.,
and Im, K. I.
(2000)
Clin. Diagn. Lab. Immunol.
7,
510-514[Abstract/Free Full Text]
|
| 37.
|
O'Connell, K. M.,
and Rogan, M. T.
(2000)
Parasitology
120,
649-655
|
| 38.
|
Freire-de-Lima, C. G.,
Nascimento, D. O.,
Soares, M. B.,
Bozza, P. T.,
Castro-Faria-Neto, H. C.,
de Mello, F. G.,
DosReis, G. A.,
and Lopes, M. F.
(2000)
Nature
403,
199-203[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Lopes, M. F.,
Nunes, M. P.,
Henriques-Pons, A.,
Giese, N.,
Morse, H. C.,
Davidson, W. F.,
Araujo-Jorge, T. C.,
and DosReis, G. A.
(1999)
Eur. J. Immunol.
29,
81-89[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Das, G.,
Vohra, H.,
Rao, K.,
Saha, B.,
and Mishra, G. C.
(1999)
Scand. J. Immunol.
49,
307-310[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
Ojcius, D. M.,
Perfettini, J. L.,
Bonnin, A.,
and Laurent, F.
(1999)
Microbes Infect.
1,
1163-1168[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
Rath, P. C.,
and Aggarwal, B. B.
(1999)
J. Clin. Immunol.
19,
350-364[CrossRef][Medline]
[Order article via Infotrieve]
|
| 43.
|
Schulze-Osthoff, K.,
Ferrari, D.,
Los, M.,
Wesselborg, S.,
and Peter, M. E.
(1998)
Eur. J. Biochem.
254,
439-459[Medline]
[Order article via Infotrieve]
|
| 44.
|
Kruidering, M.,
and Evan, G. I.
(2000)
IUBMB Life
50,
85-90[CrossRef][Medline]
[Order article via Infotrieve]
|
| 45.
|
Rathmell, J. C.,
and Thompson, C. B.
(1999)
Annu. Rev. Immunol.
17,
781-828[CrossRef][Medline]
[Order article via Infotrieve]
|
| 46.
|
Estaquier, J.,
and Ameisen, J. C.
(1997)
Blood
90,
1618-1625[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. Brannstrom, M. E. Sellin, P. Holmfeldt, M. Brattsand, and M. Gullberg
The Schistosoma mansoni Protein Sm16/SmSLP/SmSPO-1 Assembles into a Nine-Subunit Oligomer with Potential To Inhibit Toll-Like Receptor Signaling
Infect. Immun.,
March 1, 2009;
77(3):
1144 - 1154.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Bohannon, W. Cui, R. Cox, R. Przkora, E. Sherwood, and T. Toliver-Kinsky
Prophylactic Treatment with Fms-Like Tyrosine Kinase-3 Ligand after Burn Injury Enhances Global Immune Responses to Infection
J. Immunol.,
March 1, 2008;
180(5):
3038 - 3048.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|